Rinzasip with vitamin C pore. prigot. r-ra d / int. receiving sachet 5g No. 10 (lemon)
Scope of the drug
General
Release form
Powder
Manufacturer country
India
Package quantity, pcs
ten
Way of introduction
Through the mouth
Release form, composition and packaging Powder for preparation of oral solution (lemon) from light yellow to yellow with white and yellow blotches.
1 sachet
ascorbic acid (vit. C)
200 mg
caffeine
30 mg
paracetamol
750 mg
pheniramine maleate
20 mg
phenylephrine hydrochloride
10 mg
citric acid - 200 mg, sodium saccharinate - 40 mg, sodium citrate - 500 mg, sucrose - 3136 mg, quinoline yellow dye (E104) - 1 mg, lemon flavor - 83 mg.
5 g - laminated aluminum foil sachet (5) - cardboard packs 5 g - laminated aluminum foil sachets (10) - cardboard packs Pharmacological action The combined preparation has antipyretic, analgesic, alpha-adrenostimulating, vasoconstrictor and antihistaminic action. colds".
Paracetamol is a non-narcotic analgesic
blocks cyclooxygenase, mainly in the central nervous system, affecting the centers of pain and thermoregulation
has an analgesic and antipyretic effect.
Phenylephrine is an alpha-adrenergic agonist with a moderate vasoconstrictor effect.
Reduces edema and hyperemia of the mucous membranes of the upper respiratory tract and paranasal sinuses.
Pheniramine is a blocker of H1-histamine receptors.
It has an anti-allergic effect: it eliminates itching of the eyes, nose and throat, swelling and hyperemia of the mucous membranes of the nasal cavity, nasopharynx and paranasal sinuses, reduces exudative manifestations.
Caffeine has a stimulating effect on the central nervous system, enhances the effect of analgesics, eliminates drowsiness and fatigue, increases physical and mental performance, reduces fatigue and drowsiness.
Ascorbic acid (vitamin C) is involved in the regulation of redox processes, carbohydrate metabolism, blood clotting, tissue regeneration, in the synthesis of steroid hormones
Reduces vascular permeability and increases the body's resistance to the effects of various adverse environmental factors. Pharmacokinetics Data on the pharmacokinetics of Rinsasips with vitamin C are not provided. Indications for use are symptomatic treatment of colds, influenza, ARVI (febrile syndrome, pain syndrome, rhinorrhea). Contraindications to use. - the simultaneous administration of other medicines containing substances that make up the drug
- Simultaneous intake of tricyclic antidepressants, MAO inhibitors, beta-blockers
- pregnancy
- lactation period
- children's age (up to 15 years old)
- deficiency of sucrase / isomaltase, fructose intolerance, glucose-galactose malabsorption
- hypersensitivity to paracetamol and other components that make up the drug.
With caution: severe atherosclerosis of the coronary arteries, arterial hypertension, thyrotoxicosis, pheochromocytoma, diabetes mellitus, bronchial asthma, chronic obstructive pulmonary disease, deficiency of glucose-6-phosphate dehydrogenase, blood diseases, congenital hyperbilirubinemia (Gillonbert's and Dubin's liver syndrome) and / or renal failure, angle-closure glaucoma, prostatic hyperplasia. Dosage regimen Adults and children over 15 years of age are prescribed 1 sachet 3-4 times / day with intervals between doses of 4-6 hours. The maximum daily dose is 4 sachets.
The course of treatment without consulting a doctor is no more than 5 days.
Before use, the contents of 1 sachet must be poured into a glass, filled with hot water, stirred until completely dissolved and drunk (sugar or honey can be added if desired). Overdose Symptoms (mainly due to paracetamol): pallor of the skin, anorexia, nausea, vomiting
hepatonecrosis
increased activity of hepatic transaminases, increased prothrombin time.
Treatment: gastric lavage, the appointment of activated carbon, the introduction of methionine (within 8-9 hours after an overdose) and N-acetylcysteine ��(within 8-9 hours after
Dosage
etc.
x 5g
Structure
Active ingredients: paracetamol 750 mg, ascorbic acid 200 mg, caffeine 30 mg, pheniramine maleate 20 mg, phenylephrine hydrochloride 10 mg, Excipients: citric acid - 200 mg, sodium saccharinate - 40 mg, sodium citrate - 500 mg, sucrose - 3136 mg, dye - quinoline yellow (E104) - 1 mg, lemon flavor - 83 mg
Storage conditions and periods
In a dry place, at a temperature not exceeding 25 degrees.
INN / Active ingredient
phenylephrine hydrochloride + pheniramine maleate + caffeine + ascorbic acid + paracetamol
Specifications
Scope of the drug
General
Release form
Powder
Manufacturer country
India
Package quantity, pcs
ten
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Rinza
The amount of the dosage form in the primary package
5 g
Primary packaging type
Sachet (sachet)
Type of consumer packaging
Pack of cardboard
A type
Medicine
Expiration date in days
1095
The target audience
Children
Package weight, g
thirty
Category
:
Pain and fever
,
Antiviral
,
Antimicrobial agents
Dosage (volume) of the substance in the preparation
:
Caffeine - 30 mg Paracetamol - 750 mg Phenylephrine hydrochloride - 10 mg Pheniramine maleate - 20 mg
Mode of application
:
Inside.
Pour the contents of 1 sachet (sachet) into a glass, pour hot water, stir until completely dissolved and drink (you can add sugar or honey if you wish). < br> < br> Adults and children over 15 years old: take one sachet 3-4 once a day with intervals between doses of 4-6 hours. The maximum daily dose is 4 sachets.
The course of treatment without consulting a doctor - no more than 5 days
Pharmaco-therapeutic group
:
ARI and "cold" symptoms remedy (analgesic non-narcotic drug + psychostimulant + alpha-adrenergic agonist + H1-histamine receptor blocker + vitamin)
Anatomical and therapeutic characteristics
:
N02BE51 Paracetamol, in combination with other drugs (excluding psychotropic drugs)
Dosage form
:
Powder for oral solution [lemon]
Information on technical characteristics, delivery set, country of manufacture "